Urogen Pharma Ltd (URGN)

Operating Cash Flow (Statement)

-$33.01M

Quarterly · Period ending: · USD

URGN logo

URGN Operating Cash Flow (Statement)

Latest reported-$33.01M
URGN Quarterly Cash from Operations (-$1.28M → -$33.01M)
High-resolution chart · PNG

URGN operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-33,006,000
-45,316,000
-38,325,000
-42,270,000
-39,825,000
-42,024,000
-13,619,000
-27,664,000
-23,748,000
-31,735,000
-13,055,964
-17,299,000
-20,274,000
-25,807,000
-21,752,000
-16,700,036
-24,199,000
-23,996,000
-20,070,000
-18,476,000
-18,945,000
-27,401,000
-21,242,000
-25,080,000
-23,929,000
-35,635,000
-26,000,000
-12,528,000
-14,555,000
-17,934,000
-10,284,000
-9,279,000
-8,147,000
-9,624,000
-5,962,000
2,597,000
-3,461,000
-2,745,000
13,346,000
-3,526,000
-3,000,000
-2,631,000
-1,519,000
-1,331,000
-1,276,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.